Market Cap: $1.9B
XI
Xeris Biopharma Holdings, Inc.
XERS
NASDAQ (NASDAQ Global Select)USD
Market Cap: $1.9B
Xeris Biopharma's Commitment to Innovative Therapies and Patient Outcomes Xeris Biopharma Holdings, Inc., a Chicago-based biopharmaceutical company, is dedicated to transforming patient outcomes throu…
Xeris Biopharma Sets Ambitious Revenue Goals for 2024 Amid Product Growth Xeris Biopharma Holdings, Inc., a Chicago-based biopharmaceutical company, announces a positive revenue forecast for 2024, est…
Xeris Biopharma Expands Workforce with Inducement Equity Grants Xeris Biopharma Holdings, Inc., a Chicago-based biopharmaceutical company, takes a significant step in enhancing its workforce by granti…
Xeris Biopharma Expands Workforce with Strategic Inducement Grants Xeris Biopharma Holdings, Inc. announces a significant development as it grants restricted stock units (RSUs) totaling 181,500 shares…
Xeris Biopharma Holdings: Pioneering Innovative Therapeutics for Patient Care Xeris Biopharma Holdings, Inc., a biopharmaceutical company based in Chicago, is committed to enhancing patient care throu…
Xeris Biopharma Holdings Reports Record Revenues Amidst Strong Product Demand Xeris Biopharma Holdings, Inc. announces record total revenue of $54 million for the third quarter and the first nine mont…
Xeris Biopharma: Pioneering Innovative Therapies for Patient Care Xeris Biopharma Holdings, Inc., based in Chicago, is dedicated to transforming patient care through the development of groundbreaking…
Xeris Biopharma: Pioneering Innovative Therapies in Healthcare Xeris Biopharma Holdings, Inc., based in Chicago, is at the forefront of transforming patient care through its innovative biopharmaceutic…